H.Z. Turna
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 5
- Global Cancer Incidence and Screening 1
- Colorectal Cancer Treatments and Studies 1
-
- Lung Cancer Treatments and Mutations 3
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- Gilberto de Castro Junior (4 shared papers)Dariusz Mirosław Kowalski (4 shared papers)Byoung Chul Cho (4 shared papers)Tony S.K. Mok (4 shared papers)Gilberto De Lima Lopes Jr. (3 shared papers)Yi-Long Lung Cancer Wu (3 shared papers)Vichien Srimuninnimit (2 shared papers)Bogusława Karaszewska (2 shared papers)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (1 paper)The Lancet (1 paper)Indian Journal of Surgery (1 paper)
In The Last Decade
H.Z. Turna
6 papers receiving 3.0k citations
H.Z. Turna's Hit Papers
Peers
Comparison fields: 5 of 68
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 1.0k
- Cancer Research 232
- Immunology 334
- Radiology, Nuclear Medicine and Imaging 98
Countries citing papers authored by H.Z. Turna
This map shows the geographic impact of H.Z. Turna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.Z. Turna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.Z. Turna more than expected).
Fields of papers citing papers by H.Z. Turna
This network shows the impact of papers produced by H.Z. Turna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.Z. Turna. The network helps show where H.Z. Turna may publish in the future.
Co-authors
The 25 scholars most cited alongside H.Z. Turna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial Hit paper breakdown → | 2019 | 2691 |
| 2 | Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study Hit paper breakdown → | 2022 | 222 |
| 3 | 2019 | 86 | |
| 4 | 2023 | 58 | |
| 5 | 2019 | 35 | |
| 6 | 2019 | 1 |
About H.Z. Turna
H.Z. Turna is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Pathology and Forensic Medicine and Insect Science, having authored 6 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Diagnosis and Treatment (2 papers), Global Cancer Incidence and Screening (1 paper), Breast Cancer Treatment Studies (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Breast Lesions and Carcinomas (1 paper). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (1.0k citations), Cancer Research (232 citations), Immunology (334 citations) and Radiology, Nuclear Medicine and Imaging (98 citations). H.Z. Turna has collaborated with scholars based in Türkiye, Poland and Hong Kong. Frequent co-authors include Gilberto de Castro Junior, Dariusz Mirosław Kowalski, Byoung Chul Cho, Tony S.K. Mok, Gilberto De Lima Lopes Jr., Yi-Long Lung Cancer Wu, Vichien Srimuninnimit, Bogusława Karaszewska, K.K. Laktionov and Igor Bondarenko. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Lancet and Indian Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.